Assessing DCog Short for Neurotoxicity in CAR-T

Clinical trial NCT07403812 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07403812
Sponsor: Beth Israel Deaconess Medical Center
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Neurotoxicity Neurotoxicity Syndromes Hematologic Malignancy Immune Effector Cell Associated Neurotoxicity Syndrome

Start date: 2026-07-01
Primary completion: 2026-08-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.